目的 分析探讨还少丹合剂在用于血管性认知功能障碍治疗时的临床效果.方法 随机选取本院收治的72例血管性认知功能障碍患者随机等分为治疗组和对照组,对照组应用常规西医,观察组患者在此基础上加用还少丹合剂进行治疗.结果治疗前两组患者的蒙特利尔(MoCA)认知评分和日常生活能力(ADL)评分水平基本接近,P>0.05,不具有统计学意义.治疗3个月后,治疗组患者MoCA评分和ADL评分改善情况以及临床治疗效果均明显优于对照组,P<0.05,具有统计学意义.结论在西医治疗基础上给予血管性认知功能障碍患者还少丹合剂治疗,有效改善了患者的认知功能,提高了临床治疗效果.
Objective To analyze Huanshaodan mixture in the clinical effect of treatment for vascular cognitive dysfunction. Methods Randomly selected from our hospital 72 cases of vascular cognitive dysfunction patients were randomly divided into treat-ment group and control group,the control group using conventional western medicine,on the basis of the observation group patients treated with Huanshaodanmixture.Results Two groups of patients before treatment of Montreal (MoCA)cognitive scores and a-bility of daily life (ADL) score level basic close,P>0.05,is not statistically significant.3 months after treatment,the treatment group patients MoCA scores and ADL scores improvement and clinical treatment effect is better than the control group,P<0.05, statistically significant.Conclusion On the basis of western medicine treatment for vascular cognitive dysfunction in patients with Huanshaodan mixture treatment,effectively improve the cognitive function of patients,improve the clinical therapeutic effect.